首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Clinical Effect of Shenfu Injection in Patients with Septic Shock: A Meta-Analysis and Systematic Review
【24h】

Clinical Effect of Shenfu Injection in Patients with Septic Shock: A Meta-Analysis and Systematic Review

机译:参附注射液对脓毒性休克患者的临床疗效:Meta分析和系统评价

获取原文
           

摘要

Purpose. To conduct a meta-analysis evaluating the efficacy of Shenfu injection for treating patients with septic shock when compared with conventional therapy.Methods. Eight databases including Pubmed, EMBASE, Cochrane Library, ISI Web of Science, CNKI, Wanfang, VIP, and CBM were searched up to October 2014. Randomized controlled trials assessing the efficacy of Shenfu injection were identified. Mean arterial pressure, heart rate, lactate, and mortality were included as outcome measurements.Results. We analyzed data from 12 randomized controlled trials involving 904 participants. Compared with conventional therapy, Shenfu injection could further increase the mean arterial pressure at 1 hour (SMD 0.38; 95% CI, 0.01–0.74) and 6 hours (SMD 0.82; 95% CI, 0.03–1.61). Shenfu injection could further normalize heart rate at 6 hours (SMD −0.90; 95% CI, −1.47–0.33) and clear serum lactate at 6 hours (SMD −0.51; 95% CI, −0.70–0.32) and 24 hours (SMD, 0.52; 95% CI, −0.77–0.26). As the endpoint of mortality was not unified, it was not meta-analyzed.Conclusions. Based on the findings in present review, Shenfu injection is more effective than conventional therapy in increasing mean arterial pressure, normalizing heart rate, clearing serum lactate, and reducing mortality. These results should be confirmed in higher level clinical trials in the future.
机译:目的。进行荟萃分析,评估参附注射液治疗败血性休克与传统疗法相比的疗效。截至2014年10月,共检索了八个数据库,包括Pubmed,EMBASE,Cochrane图书馆,ISI Web of Science,CNKI,Wanfang,VIP和CBM。确定了评估参附注射液疗效的随机对照试验。平均动脉压,心率,乳酸盐和死亡率均包括在结局指标中。我们分析了来自904名参与者的12项随机对照试验的数据。与常规疗法相比,参附注射液可进一步增加1小时(SMD 0.38; 95%CI,0.01-0.74)和6小时(SMD 0.82; 95%CI,0.03-1.61)的平均动脉压。参附注射液可在6小时(SMD −0.90; 95%CI,-1.47–0.33)进一步使心率正常化,并在6小时(SMD −0.51; 95%CI,−0.70–0.32)和24小时(SMD)清除血清乳酸。 ,0.52; 95%CI,-0.77-0.26)。由于死亡率的终点不统一,因此未进行荟萃分析。根据目前的研究结果,参附注射液在增加平均动脉压,使心率正常化,清除血清乳酸盐和降低死亡率方面比传统疗法更有效。这些结果应在以后的更高水平的临床试验中得到证实。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号